Deutsche Bank’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Sell
128,319
-2,767
-2% -$5.55K ﹤0.01% 2810
2025
Q4
$180K Sell
131,086
-9,695
-7% -$12.8K ﹤0.01% 3066
2025
Q3
$175K Buy
140,781
+61,579
+78% +$73.4K ﹤0.01% 3126
2025
Q2
$89.5K Sell
79,202
-20,342
-20% -$27K ﹤0.01% 3300
2025
Q1
$145K Buy
99,544
+92,981
+1,417% +$175K ﹤0.01% 3085
2024
Q4
$14K Sell
6,563
-62,616
-91% -$154K ﹤0.01% 3505
2024
Q3
$194K Buy
69,179
+30,994
+81% +$82.6K ﹤0.01% 2943
2024
Q2
$89K Sell
38,185
-6,699
-15% -$19.8K ﹤0.01% 3156
2024
Q1
$201K Buy
44,884
+2,222
+5% +$9.27K ﹤0.01% 2817
2023
Q4
$137K Sell
42,662
-628
-1% -$1.78K ﹤0.01% 3073
2023
Q3
$137K Sell
43,290
-193,776
-82% -$849K ﹤0.01% 3010
2023
Q2
$1.18M Sell
237,066
-210,884
-47% -$1.14M ﹤0.01% 1902
2023
Q1
$2.21M Buy
447,950
+1,200
+0.3% +$7.7K ﹤0.01% 1636
2022
Q4
$2.81M Buy
446,750
+6,939
+2% +$64.2K ﹤0.01% 1472
2022
Q3
$4.75M Sell
439,811
-47,820
-10% -$650K ﹤0.01% 1234
2022
Q2
$5.56M Buy
487,631
+98,865
+25% +$878K ﹤0.01% 1232
2022
Q1
$3.54M Buy
388,766
+44,240
+13% +$461K ﹤0.01% 1566
2021
Q4
$5.14M Buy
344,526
+132,937
+63% +$2.35M ﹤0.01% 1422
2021
Q3
$5.44M Sell
211,589
-22,194
-9% -$527K ﹤0.01% 1456
2021
Q2
$6.1M Buy
233,783
+33,832
+17% +$965K ﹤0.01% 1410
2021
Q1
$7.06M Sell
199,951
-60,967
-23% -$2.06M ﹤0.01% 1372
2020
Q4
$6.59M Buy
260,918
+206,099
+376% +$6.72M ﹤0.01% 1224
2020
Q3
$2.07M Sell
54,819
-9,795
-15% -$369K ﹤0.01% 1727
2020
Q2
$2.77M Buy
64,614
+49,351
+323% +$1.78M ﹤0.01% 1611
2020
Q1
$297K Sell
15,263
-3,512
-19% -$83.7K ﹤0.01% 2747
2019
Q4
$486K Buy
18,775
+7,291
+63% +$201K ﹤0.01% 2734
2019
Q3
$312K Sell
11,484
-10,280
-47% -$293K ﹤0.01% 2924
2019
Q2
$582K Sell
21,764
-18,950
-47% -$528K ﹤0.01% 3177
2019
Q1
$1.17M Buy
40,714
+3,414
+9% +$99.1K ﹤0.01% 2884
2018
Q4
$1M Buy
+37,300
New +$991K ﹤0.01% 2880

Other funds holding ALLO